[1] Kleyweqt S,Pileqqi V,Yang P,et al. Pharmaceuticals,hormones and bisphenol A in untreated source and finished drinking water in On-tario,Canada:Occurrence and treatment efficiency[J]. Sci. Total En-viron.,2011,409(8):1481-1488.
[2] Lissemore L,Hao C,Yang P,et al. An exposure assessment for selec-ted pharmaceuticals within a watershed in Southern Ontario [J]. Che-mosphere,2006,64(5):717-729.
[3] Oaks J L,Gilbert M,Virani M Z,et al. Diclofenac residues as the cause of vulture population decline in Pakistan[J]. Nature,2004,427(6975):630-633.
[4] Coxib and traditional NSALD trialist collaboration. Vascular and up-per gastrointestinal effects of non-steroidal anti-inflammatory drugs:Meta-analyses of individual participant data from randomised tri-als[J]. The Lancet,2013,382(9894):60900-60909.
[5] Yang X,Flowers R C,Weinberg H S,et al. Occurrence and removal of pharmaceuticals and personal care products(PPCPs) in an advan-ced wastewater reclamation plant[J]. Water Research,2011,45(16):5218-5228.
[6] Sipma J,Osuna B,Collado N,et al. Comparison of removal of phar-maceuticals in MBR and activated sludge systems[J]. Desalination,2010,250(2):653-659.
[7] Bernhard M,Müller J,Knepper T P. Biodegradation of persistent po-lar pollutants in wastewater:Comparison of an optimised lab-scale membrane bioreactor and activated sludge treatment[J]. Water Re-search,2006,40(18):3419-3428.
[8] Verlicchi P,Al Aukidy M,Zambello E. Occurrence of pharmaceutical compounds in urban wastewater:Removal,mass load and environ-mental risk after a secondary treatment-A review[J]. Sci. Total En-viron.,2012,429:123-155.
[9] Clara M,Strenn B,Gans O,et al. Removal of selected pharmaceuti-cals,fragrances and endocrine disrupting compounds in a membrane bioreactor and conventional wastewater treatment plants[J]. Water Research,2005,39(19):4797-4807.
[10] Gobel A,McArdell C S,Joss A,et al. Fate of sulfonamides,macro-lides,and trimethoprim in different wastewater treatment technologies[J]. Sci. Total Environ.,2007,372(2/3):361-371.
[11] Joss A,Keller E,Alder A C,et al. Removal of pharmaceuticals and fragrances in biological wastewater treatment[J]. Water Research,2005,39(14):3139-3152.
[12] Roberts P H,Thomas K V. The occurrence of selected pharmaceuti-cals in wastewater effluent and surface waters of the lower Tyne catchment[J]. Sci. Total Environ.,2006,356:143-153.
[13] Xu J,Wu L,Chang A C. Degradation and adsorption of selected pharmaceuticals and personal care products(PPCPs) in agricultural soils[J]. Chemosphere,2009,77(10):1299-1305.
[14] Urase T,Kikuta T. Separate estimation of adsorption and degrada-tion of pharmaceutical substances and estrogens in the activated sludge process[J]. Water Research,2005,39(7):1289-1300.
[15] Joss A,Andersen H,Ternes T,et al. Removal of estrogens in muni-cipal wastewater treatment under aerobic and anaerobic conditions: Consequences for plant optimization[J]. Environmental Science and Technology,2004,38(11):3047-3055.